• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QRS 时限或 QRS 形态:心脏再同步治疗中真正重要的是什么?

QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?

机构信息

Department of Medicine, University of Washington, Seattle, Washington.

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Coll Cardiol. 2016 Mar 8;67(9):1104-1117. doi: 10.1016/j.jacc.2015.12.039.

DOI:10.1016/j.jacc.2015.12.039
PMID:26940932
Abstract

The beneficial effects of cardiac resynchronization therapy (CRT) have been well established in large, randomized trials. Despite the documented success of this treatment strategy, a significant proportion of patients with heart failure do not achieve the desired response. The aim of this review was to delineate factors contributing to a successful CRT response, emphasizing the interrelated roles of QRS morphology and QRS interval duration. More data are available on QRS duration, as this factor has been used as an enrollment criterion in clinical trials. Response to CRT seems to increase as the QRS duration becomes longer, with greatest benefit in QRS duration ≥150 ms. Recent data have placed more emphasis on QRS morphology, demonstrating variability in clinical response between patients with left bundle branch block, non-left bundle branch block, and right bundle branch block morphology. Notably, myocardial scarring and cardiac dimensions, among other variables, may alter heterogeneity in ventricular activation. Understanding the electrophysiological underpinnings of the QRS complex has become important not only to predict response but also to facilitate the patient-specific delivery of resynchronization therapy.

摘要

心脏再同步治疗(CRT)的有益效果已在大型随机试验中得到充分证实。尽管这种治疗策略取得了有案可稽的成功,但仍有相当一部分心力衰竭患者未能达到预期的反应。本综述的目的是阐明导致 CRT 反应成功的因素,强调 QRS 形态和 QRS 间隔持续时间的相互关联作用。更多的数据可用于 QRS 持续时间,因为该因素已被用作临床试验中的入组标准。随着 QRS 持续时间的延长,对 CRT 的反应似乎会增加,而 QRS 持续时间≥150ms 的获益最大。最近的数据更加重视 QRS 形态,表明左束支传导阻滞、非左束支传导阻滞和右束支传导阻滞形态的患者之间的临床反应存在差异。值得注意的是,心肌瘢痕和心脏尺寸等其他变量可能改变心室激动的异质性。了解 QRS 复合体的电生理基础不仅对预测反应很重要,而且对促进针对患者的心脏再同步治疗也很重要。

相似文献

1
QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?QRS 时限或 QRS 形态:心脏再同步治疗中真正重要的是什么?
J Am Coll Cardiol. 2016 Mar 8;67(9):1104-1117. doi: 10.1016/j.jacc.2015.12.039.
2
Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.无左束支传导阻滞的轻度心力衰竭患者中QRS时限与心脏再同步治疗临床获益的关系:心脏再同步治疗多中心自动除颤器植入试验子研究
Circ Heart Fail. 2016 Feb;9(2):e002667. doi: 10.1161/CIRCHEARTFAILURE.115.002667.
3
Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.非左束支传导阻滞形态患者对心脏再同步治疗反应的预测因素。
Am J Cardiol. 2011 Dec 1;108(11):1576-80. doi: 10.1016/j.amjcard.2011.07.017. Epub 2011 Sep 3.
4
Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block.左束支传导阻滞患者QRS波时限与心脏再同步治疗反应的关系
Am J Cardiol. 2017 Jun 1;119(11):1803-1808. doi: 10.1016/j.amjcard.2017.02.043. Epub 2017 Mar 16.
5
Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.女性与男性的心脏再同步治疗:来自国家心血管数据登记处的观察性比较疗效研究。
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S4-11. doi: 10.1161/CIRCOUTCOMES.114.001548. Epub 2015 Feb 24.
6
Effect of PR interval prolongation on long-term outcomes in patients with left bundle branch block vs non-left bundle branch block morphologies undergoing cardiac resynchronization therapy.左束支传导阻滞与非左束支传导阻滞形态患者心脏再同步治疗中 PR 间期延长对长期预后的影响。
Heart Rhythm. 2017 Oct;14(10):1523-1528. doi: 10.1016/j.hrthm.2017.05.028. Epub 2017 May 24.
7
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
8
Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy.瘢痕负荷而非室内传导延迟模式与接受心脏再同步治疗的缺血性心肌病患者的结局相关。
Heart Rhythm. 2018 Nov;15(11):1664-1672. doi: 10.1016/j.hrthm.2018.05.027. Epub 2018 May 28.
9
QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.QRS 频率特征有助于预测左束支传导阻滞小于 150 毫秒的心脏再同步反应。
Heart Rhythm. 2014 Dec;11(12):2183-9. doi: 10.1016/j.hrthm.2014.07.034. Epub 2014 Jul 25.
10
[Results of randomized studies on cardiac resynchronization therapy and the reevaluation of cardiac ventricular activation in left bundle branch block].[心脏再同步治疗的随机研究结果及左束支传导阻滞中心室激动的重新评估]
Orv Hetil. 2013 May 5;154(18):688-93. doi: 10.1556/OH.2013.29596.

引用本文的文献

1
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias.《日本循环学会/日本心律学会2024年心律失常管理指南重点更新》
J Arrhythm. 2025 Jun 16;41(3):e70033. doi: 10.1002/joa3.70033. eCollection 2025 Jun.
2
Relationship between electrocardiographic characteristics and subclinical left ventricular systolic dysfunction in isolated left bundle branch block patients.孤立性左束支传导阻滞患者心电图特征与亚临床左心室收缩功能障碍的关系。
Cardiovasc Ultrasound. 2025 May 1;23(1):7. doi: 10.1186/s12947-025-00342-6.
3
Impact of polypharmacy on clinical outcomes in patients with advanced heart failure undergoing cardiac resynchronization therapy.
多重用药对接受心脏再同步治疗的晚期心力衰竭患者临床结局的影响。
J Arrhythm. 2024 Nov 22;41(1):e13185. doi: 10.1002/joa3.13185. eCollection 2025 Feb.
4
Identifying non-responders to cardiac resynchronization therapy in the non-left bundle branch block.识别非左束支传导阻滞患者中对心脏再同步治疗无反应者。
J Interv Card Electrophysiol. 2025 Jan 3. doi: 10.1007/s10840-024-01972-y.
5
Conduction System Pacing for Heart Failure.心力衰竭的传导系统起搏
Tex Heart Inst J. 2024 Dec 13;51(2):e248469. doi: 10.14503/THIJ-24-8469. eCollection 2024 Jul-Dec.
6
Left bundle branch area pacing vs biventricular pacing for cardiac resynchronization: A systematic review and meta-analysis.心脏再同步治疗中左束支区域起搏与双心室起搏的比较:一项系统评价和荟萃分析。
Heart Rhythm O2. 2023 Nov 11;4(11):671-680. doi: 10.1016/j.hroo.2023.06.011. eCollection 2023 Nov.
7
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023年美国心律学会/亚太心律学会/拉丁美洲心律学会关于避免和减轻心力衰竭的心脏生理性起搏指南。
J Arrhythm. 2023 Aug 2;39(5):681-756. doi: 10.1002/joa3.12872. eCollection 2023 Oct.
8
Pacing for atrioventricular block with preserved left ventricular function: On-treatment comparison between his bundle, left bundle branch, and right ventricular pacing.左心室功能保留的房室传导阻滞的起搏治疗:希氏束起搏、左束支起搏和右心室起搏的治疗效果比较
Indian Pacing Electrophysiol J. 2023 Nov-Dec;23(6):196-202. doi: 10.1016/j.ipej.2023.09.006. Epub 2023 Sep 28.
9
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023 年 HRS/APHRS/LAHRS 心脏生理起搏指南:预防和减轻心力衰竭。
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.
10
His-Purkinje system pacing versus biventricular pacing in clinical efficacy: a systematic review and meta-analysis.希氏-浦肯野系统起搏与双心室起搏在临床疗效方面的比较:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Jun 3;23(1):285. doi: 10.1186/s12872-023-03307-7.